Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The role of p53 in chemosensitivity and radiosensitivity

Abstract

The role of p53 as a central mediator of the DNA damage and other cellular stress responses is well established. The ultimate growth-suppressive function of p53 in part explains its ability to confer chemosensitivity and radiosensitivity upon tumor cells. Recent work in the field has added complexity to our understanding, in terms of identifying novel regulators of p53 stability and function, elucidation of the importance of the p53 family towards p53 function, a growing list of transcriptional targets as well as transcription-independent apoptotic effects and mechanisms, tissue specificity of the p53 response, a molecular understanding of p53-dependent therapeutic sensitization, and efforts towards molecular targeting of the p53 pathway. p53 remains an attractive target for drug development in cancer because its alteration provides a fundamental difference between normal and cancer cells. Strategies are emerging for the identification of mutant p53-specific therapies, therapies targeted at mutant p53-expressing tumors, as well as therapies that target various aspects of the p53 life cycle to enhance chemosensitization. The tools of molecular imaging are beginning to accelerate the pace of discovery and preclinical testing of p53 in animal models. The future holds promise for specific, individualized targeting of mutant or wild-type p53, or its transcriptional targets, in combination therapies with other cancer-specific drugs, to maximize tumor cell killing while protecting normal cells from toxic side effects.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Amundson SA, Patterson A, Do KT and Fornace AJ . (2002). Cancer Biol. Ther., 1, 145–149.

  • An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM . (1998). Nature, 392, 405–408.

  • Ashcroft M, Taya Y and Vousden KH . (2000). Mol. Cell. Biol., 20, 3224–3233.

  • Badciong JC and Haas AL . (2002). J. Biol. Chem., 277, 49668–49675.

  • Bakkenist CJ and Kastan MB . (2003). Nature, 421, 499–506.

  • Basu S, Totty NF, Irwin MS, Sudol M and Downward J . (2003). Mol. Cell, 11, 11–23.

  • Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Marlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X and Crook T . (2003a). Cancer Cell, 3, 387–402.

  • Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE and Lu X . (2003b). Nat. Genet., 33, 162–167.

  • Blagosklonny MV and El-Deiry WS . (1996). Int. J. Cancer, 67, 386–392.

  • Blagosklonny MV and El-Deiry WS . (1998). Int. J. Cancer, 75, 933–940.

  • Bottger A, Bottger V, Sparks A, Liu WL, Howard SF and Lane DP . (1997). Curr. Biol., 7, 860–869.

  • Bottger V, Bottger A, Howard SF, Picksley SM, Chene P, Garcia Echeverria C, Hochkeppel HK and Lane DP . (1996). Oncogene, 13, 2141–2147.

  • Brooks CL and Gu W . (2003). Curr. Opin. Cell Biol., 15, 164–171.

  • Burns TF, Bernhard EJ and El-Deiry WS . (2001). Oncogene, 20, 4601–4612.

  • Burns TF and El-Deiry WS . (2003). Cancer Treat Res., 115, 319–343.

  • Burns TF, Fei P, Scata KA, Dicker DT and El-Deiry WS . (2003). Mol. Cell. Biol., 23, 5556–5571.

  • Bykov VJN, Issaeva N, Shilov A, Hulcrantz M, Pugacheva E, Chumakov P, Bergman J, Wiman KG and Selivanova G . (2002). Nat. Med., 8, 282–288.

  • Caelles C, Helmberg A and Karin M . (1994). Nature, 370, 220–223.

  • Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D and Keshet E . (1998). Nature, 394, 485–490.

  • Chehab NH, Malikzay A, Stavridi ES and Halazonetis TD . (1999). Proc. Natl. Acad. Sci. USA, 96, 13777–13782.

  • Cho YJ, Gorina S, Jeffrey PD and Pavletich NP . (1994). Science, 265, 346–355.

  • Choi J, Nannenga B, Demidov ON, Bulavin DV, Cooney A, Brayton C, Zhang YX, Mbawuike IN, Bradley A, Appella E and Donehower LA . (2002). Mol. Cell. Biol., 22, 1094–1105.

  • Deb SP . (2002). Front Biosci., 7, D235–D243.

  • Deng CX, Zhang PM, Harper JW, Elledge SJ and Leder P . (1995). Cell, 82, 675–684.

  • Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R and Tjuvajev JG . (2001). Proc. Natl. Acad. Sci. USA, 98, 9300–9305.

  • Dumaz N, Milne DM and Meek DW . (1999). FEBS Lett., 463, 312–316.

  • Dumont P, Leu JI-J, Della Tietra III AC, George DL and Murphy M . (2003). Nat. Genet., 33, 357–365.

  • El-Deiry WS . (1998). Semin. Cancer Biol., 8, 345–357.

  • El-Deiry WS . (2001). Cell Death Differ., 8, 1066–1075.

  • El-Deiry WS . (2002). Cancer Biol. Ther., 1, 490–491.

  • El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang YS, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B (1994). Cancer Res., 54, 1169–1174.

  • Fei P, Bernhard EJ and El-Deiry WS . (2002). Cancer Res., 62, 7316–7327.

  • Finch RA, Donoviel DB, Potter D, Shi M, Fan A, Freed DD, Wang CY, Zambrowicz BP, Ramirez-Solis R, Sands AT and Zhang N . (2002). Cancer Res., 62, 3221–3225.

  • Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F and Jacks T . (2002). Nature, 416, 560–564.

  • Foster BA, Coffey HA, Morin MJ and Rastinejad F . (1999). Science, 286, 2507–2510.

  • Freeman DJ, Li AG, Wei G, Li H-H, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X and Wu H . (2003). Cancer Cell, 3, 117–130.

  • Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill JC, Blasco MA and Serrano M . (2002). EMBO J., 21, 6225–6235.

  • Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y and Livingston DM . (2003). Science, 300, 342–344.

  • Hamid O, Varterasian ML, Wadler S, Hecht JR, Benson A, Galanis E, Uprichard M, Omar C, Bycott P, Hackman RC and Shields AF . (2003). J. Clin. Oncol., 21, 1498–1504.

  • Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH and Freeman SM . (2003). Clin. Cancer Res., 9, 555–561.

  • Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, Hannon GJ and Lowe SW . (2003). Nat. Genet., 33, 396–400.

  • Herbert BS, Pearce VP, Hyman LS, LaRue DM, Wright WE, Kopelovich L and Shay JW . (2003). Cancer Res., 63, 1914–1919.

  • Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, Okada H, Sarkissian T, Wong JA, Sakai T, de Stanchina E, Bristow RG, Suda T, Lowe SW, Jeggo PA, Elledge SJ and Mak TW . (2002). Mol. Cell. Biol., 22, 6521–6532.

  • Hoffman WH, Biade S, Zilfou JT, Chen JD and Murphy M . (2002). J. Biol. Chem., 277, 3247–3257.

  • Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC and Kaelin WG . (2003). Cancer Cell, 3, 403–410.

  • Jimenez GS, Nister M, Stommel JM, Beeche M, Barcarse EA, Zhang XQ, O’Gorman S and Wahl GM . (2000). Nat. Genet., 26, 37–42.

  • Kastan MB and Zambetti GP . (2003). Cell, 112, 1–2.

  • Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV . (1999). Science, 285, 1733–1737.

  • Komarova EA, Neznanov N, Komarov PG, Chernov MV, Wang K and Gudkov AV . (2003). J. Biol. Chem., 278, 15465–15468.

  • Koumenis C, Alarcon R, Hammond D, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M and Giaccia A . (2001). Mol. Cell. Biol., 21, 1297–1310.

  • Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD and Rehemtulla A . (2002). Proc. Natl. Acad. Sci. USA, 99, 16551–16555.

  • Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R and Benchimol S . (2003). Cell, 112, 779–791.

  • Li MY, Chen DL, Shiloh A, Luo JY, Nikolaev AY, Qin J and Gu W . (2002). Nature, 416, 648–653.

  • Lowe SW and Sherr CJ . (2003). Curr. Opin. Genet. Dev., 13, 77–83.

  • Lowe SW, Ruley HE, Jacks T and Housman DE . (1993). Cell, 74, 957–967.

  • MacLachlan TK and El-Deiry WS . (2002). Proc. Natl. Acad. Sci. USA, 99, 9492–9497.

  • MacLachlan TK, Takimoto R and El-Deiry WS . (2002). Mol. Cell. Biol., 22, 4280–4292.

  • Manfredi JJ . (2003). Mol. Cell, 11, 552–554.

  • Massoud TF and Gambhir SS . (2003). Genes Dev., 17, 545–580.

  • Maya R, Balass M, Kim ST, Shkedy D, Leal JFM, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E and Oren M . (2001). Genes Dev., 15, 1067–1077.

  • Melino G, De Laurenzi V and Vousden KH . (2002). Nat. Rev. Cancer, 2, 605–615.

  • Michael D and Oren M . (2003). Semin. Cancer Biol., 13, 49–58.

  • Midgley CA, Desterro JMP, Saville MK, Howard S, Sparks A, Hay RT and Lane DP . (2000). Oncogene, 19, 2312–2323.

  • Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM . (2003). Mol. Cell, 11, 577–590.

  • Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K . (2001). Nat. Cell. Biol., 3, 552–558.

  • Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ and George DL . (1999). Genes Dev., 13, 2490–2501.

  • Nikolaev AY, Li MY, Puskas N, Qin J and Gu W . (2003). Cell, 112, 29–40.

  • Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA and Ji L . (2001). Clin. Cancer Res., 7, 2887–2897.

  • O'Connor PM, Jackman J, Bae I, Myers TG, Fan SJ, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJ and Kohn KW . (1997). Cancer Res., 57, 4285–4300.

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N . (2000). Science, 288, 1053–1058.

  • Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, Duyk J, Friedman L, Prives C and Kopczynski C . (2000). Cell, 101, 91–101.

  • Peng Y, Li C, Chen L, Sebti S and Chen J . (2003). Oncogene, 22, 4478–4487.

  • Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B . (1997). Nature, 389, 300–305.

  • Rippin TM, Bykov VJN, Freund SMV, Selivanova G, Wiman KG and Fersht AR . (2002). Oncogene, 21, 2119–2129.

  • Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T and Lu X . (2001). Mol. Cell, 8, 781–794.

  • Sax JK and El-Deiry WS . (2003). Cell Death Differ., 10, 413–417.

  • Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ and El-Deiry WS . (2002). Nat. Cell. Biol., 4, 842–849.

  • Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM and Lowe SW . (2002). Cell, 109, 335–346.

  • Slee EA and Lu X . (2003). Toxicol. Lett., 139, 81–87.

  • Soengas MS, Capodieci P, Polsky D, Mora J, Estellar M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW . (2001). Nature, 409, 207–211.

  • Song E, Lee S-K, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P and Lieberman J . (2003). Nat. Med., 9, 347–351.

  • Soussi T . (2003). Cancer Cell, 3, 303–305.

  • Takimoto R and El-Deiry WS . (2000). Oncogene, 19, 1735–1743.

  • Takimoto R, MacLachlan TK, Dicker DT, Niitsu Y, Mori T and El-Deiry WS . (2002a). Cancer Biol. Ther., 1, 177–186.

  • Takimoto R, Wang W, Dicker DT, Rastinejad F, Lyssikatos J and El-Deiry WS . (2002b). Cancer Biol. Ther., 1, 47–55.

  • Tan T and Chu G . (2002). Mol. Cell. Biol., 22, 3247–3254.

  • Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y . (2000). Nature, 404, 42–49.

  • Tanikawa C, Matsuda K, Fukuda S, Nakamura Y and Arakawa H . (2003). Nat. Cell. Biol., 5, 216–223.

  • Velculescu VE and El-Deiry WS . (1996). Clin. Chem., 42, 858–868.

  • Vogelstein B and Kinzler KW . (1992). Cell, 70, 523–526.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Vousden KH . (2000). Cell, 103, 691–694.

  • Vousden KH and Lu X . (2002). Nat. Rev. Cancer, 2, 594–604.

  • Waldman T, Zhang YG, Dillehay L, Yu J, Kinzler K, Vogelstein B and Williams J . (1997). Nat. Med., 3, 1034–1036.

  • Walker KK and Levine AJ . (1996). Proc. Natl. Acad. Sci. USA, 93, 15335–15340.

  • Wang W and El-Deiry WS . (2003). Cancer Biol. Ther., 2, 196–202.

  • Wang W, Takimoto R, Rastinejad F and El-Deiry WS . (2003). Mol. Cell. Biol., 23, 2171–2181.

  • Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ . (2001). Science, 292, 727–730.

  • Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, vanOsdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD . (1997). Science, 275, 343–349.

  • Wu GS and El-Deiry WS . (1996). Clin. Cancer Res., 2, 623–633.

  • Yin YX, Liu YX, Jin YJ, Hall EJ and Barrett JC . (2003). Nature, 422, 527–531.

  • Yu J, Wang ZH, Kinzler KW, Vogelstein B and Zhang L . (2003). Proc. Natl. Acad. Sci. USA, 100, 1931–1936.

  • Zhou BHP and Hung MC . (2002). Semin. Oncol., 29, 62–70.

  • Zhou BHP, Liao Y, Xia WY, Zou YY, Spohn B and Hung MC . (2001). Nat. Cell. Biol., 3, 973–982.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wafik S El-Deiry.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Deiry, W. The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22, 7486–7495 (2003). https://doi.org/10.1038/sj.onc.1206949

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206949

Keywords

This article is cited by

Search

Quick links